Dr Mei-Heng Tan 

 

Dr Mei-Heng Tan graduated from the University of Sydney, Australia in 1995. She was selected to join The Department of Dermatology at The Mount Sinai School of Medicine, New York, N.Y. upon completion of an internship and research at Mount Sinai.

She was awarded a Laser and Cosmetic Surgery Fellowship in Boston, training with Professors from Harvard and Yale.

Dr Tan was a consultant and associate at renowned U.S. dermatology practice, Orentreich Medical Group, Fifth Avenue, New York, where she mastered the microdroplet injection filler technique and established herself as an authority on laser skin rejuvenation modalities Fraxel and Thermage.

I offer a range of innovative options for attaining smooth soft skin through cosmetic surgery, laser expertise and the most advanced technology. I deliver the highest levels of personalised attention with ethical, skilled, comprehensive care, providing patients with unparalleled service."

Practicing alongside her husband Dr Weng Sehu an ophthalomologist and oculoplastic surgeon, you will have the unique opportunity to be assessed by two specialist surgeons, offering a full spectrum of surgical and non surgical cosmetic procedures.

Publications 

REVIEWER:

Journal of the American Academy of Dermatology: 1998, 1999
Archives of Dermatology: 2001, 2002
Journal of Cutaneous Medicine and Surgery: 2005

PRESENTATIONS:

  • Fillers for facial rejuvenation. Laser and Cosmetic Medicine Conference. Amora Jamison Hotel, Sydney, Australia. 17.2.2007

  • The effect of monopolar radiofrequency on fillers. Filler Symposium. Vth World Congress of the International Academy of Cosmetic Dermatology. Melbourne, Australia. 12.12.2006. 

  • Botox A and Resurfacing. “Combining Techniques with Botox A” Symposium. Vth World Congress of the International Academy of Cosmetic Dermatology. Melbourne, Australia. 11.12.2006.

  • Non-ablative Skin Tightening. “Lasers, Lights, Radiofrequency, Plasma and New Technologies” Symposium. Vth World Congress of the International Academy of Cosmetic Dermatology. Melbourne, Australia. 11.12.2006.

  • Fraxel Resurfacing Workshop, Treating Physician - Australian College of Cosmetic Surgery, Adelaide, Australia, May 2006. 

  • Fraxel Laser Workshop, Treating Physician - Eighth Annual Mount Sinai Winter Symposium, Advances in Medical and Surgical Dermatology, December 2005, New York, NY. December 2005.

  • The penetration of fluticasone propionate ointment 0.005% through eyelid skin. Scientific Session, The Mount Sinai Winter Symposium, Advances in Medical and Surgical Dermatology, December 2000, New York, NY.

  • The penetration of fluticasone propionate ointment 0.005% through eyelid skin. 13th Annual Conrad Stritzler Resident’s Competition January 24th, 2002, Lennox Hill Hospital, New York, NY.

PUBLICATIONS:

  1. Tan M-H, Commens C.A, Burnett L. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australasian Journal of Dermatology 37:185-7,1996.

  2. Solganick J, Tan M-H, Lebwohl M. Adverse effects of systemic psoriasis treatments: Cyclosporin. National Psoriasis Foundation Forum 4(1):5, 1998.

  3. Tan M-H, Solganick J, Lebwohl M. Adverse effects of systemic psoriasis treatments: Retinoids. National Psoriasis Foundation Forum 3(4):6-7, 1997.

  4. Solganick J, Tan M-H, Lebwohl M. Adverse effects of systemic psoriasis treatments: Methotrexate. National Psoriasis Foundation Forum 3(4):4-5, 1997.

  5. Lebwohl M, Tan M-H. Commentary on Psoriasis and Stress. Lancet 351 (9096):82, 1998.

  6. Tan M-H, Lebwohl M. Psoriasis. Drugs of Today 34(7):641-7, 1998.

  7. Meador S, Tan M-H, Lebwohl M. Problem psoriasis cases and solutions. National Psoriasis Foundation Forum 4(4):1-2, 1998.

  8. Lebwohl M, Gelfand J, Tan M-H. Clinically significant therapeutic interactions for the practicing dermatologist.Advances in Dermatology 14:1-27, 1999.

  9. Tan M-H, Lebwohl M, Esser A, Wei H. The penetration of fluticasone propionate ointment 0.005% in eyelid skin. J Am Acad Dermatol 45(3) September 2001, 392-396.

  10. Lebwohl M, Lombardi K, Tan M-H. Duration of remission of psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: Comparison of maintenance treatments. Int J Dermatol 40(1) Jan 2001, 64-6.

  11. Tan M-H, Meador S, Singer G, Lebwohl M. The safety and efficacy of limited application of fluticasone propionate ointment 0.005% in patients with atopic dermatitis of the face and intertriginous areas. Int J Dermatol (41) November 2002, 804-9.

  12. Lebwohl M, Tan M-H, Meador S, Singer G. The safety and efficacy of limited application of fluticasone propionate ointment 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol January 2001, 77-82.

  13. Tan M-H, Gordon M, Lebwohl O, George J, Lebwohl M. Improvement of pyoderma gangrenosum and psoriasis associated with Crohn’s disease with tumor necrosis factor-alpha. Arch Dermatol 137(7) July 2001, pp 930-933.

  14. Tan M-H, Spencer J, Monteiro Pires L, Ajmeri J, Skover G. The evaluation of aluminum oxide crystal microdermabrasion for photodamage. Dermatol Surg 27(11) November 2001, 943-949.

  15. Bershad S, Singer GK, Tan M-H, Sherer D, Lebwohl M. Successful treatment of acne vulgaris using a new method:results of a double-blind vehicle-controlled trial of short-contact therapy with tazarotene 0.1% gel. Arch Dermatol 138 April 2002, 481-489.

  16. Bartsch M. Tan M-H. Miliaria, Ch 128, In Lebwohl, Heymann, Berth-Jones, Coulson. Treatment of Dermatologic Skin Disease. Comprehensive therapeutic strategies. Mosby International, London, 2002.

  17. Lamba S, Tan M-H, Krishtul A, Lebwohl M. Acanthosis nigricans in a plaque of scleredema on the back of a diabetic patient: a case report. Int J Dermatol (44:1) January 2004, 45-47.

  18. Croitoru A G, Birge M, Rudikoff D, Tan M-H, Phelps R G. Tanapox virus infection. Skin Med 1(2) November/December 2002, 156-7.

  19. Kaminer MS, Tan M-H, Hsu TS, Alam M. Limited breast reduction by liposuction. Skin Therapy Letter Dec2002;7 (10):6-8.

  20. Comite SL, Krishtul A, Tan M-H. Using microdermabrasion to treat sun-induced facial lentigines and photoaging.Cosmetic Dermatology 16 (4) April 2003, 40-42.

  21. Hsu TS, Dover JS, Kaminer MS, Arndt KA, Tan M-H. Why make patients exercise facial muscles for 4 hours after botulinum toxin treatment? Arch Dermatol 139 (7) July 2003, 948.

  22. Tan M-H, Dover JS, Hsu T-S, Arndt KA, Stewart B. Clinical evaluation of enhanced nonablative skin rejuvenation using a combination of a 532 nm and a 1064 nm laser. Lasers in Surgery and Medicine 34(5) July 2004, 439.

  23. England LJ, Tan M-H, Shumaker PR, Egbert BR, Pittelko K, Orentreich D, Pope K. Effects of Monopolar Radiofrequency Treatment Over Soft-Tissue Fillers in an Animal Model. Lasers in Surgery and Medicine 37(5) December 2005, 356-365.

  24. Zhao CY, Ang RYN, George R, Tan M-H, Murrell DF. The quality of dermatology consultation documentation in discharge summaries: a retrospective analysis. International Journal of Women's Dermatology 2016, 23-27. 

ABSTRACTS:

  1. The penetration of fluticasone propionate ointment 0.005% through eyelid skin. 
    Poster abstract exhibit, AmericanAcademy of Dermatology 57th Annual Meeting, New Orleans, LA. March 1999.
    Poster abstract exhibit, Advances in Medical and Surgical Dermatology for the New Millennium Mount Sinai School of Medicine Department of Dermatology, December 10-12, 1999 New York, N.Y.

  2. The safety and efficacy of limited application of fluticasone propionate ointment 0.005% in patients with atopic dermatitis of the face and intertriginous areas. 
    Poster abstract exhibit, AmericanAcademy of Dermatology 57th Annual Meeting, New Orleans, LA. March, 1999. 

  3. The safety and efficacy of limited application of fluticasone propionate ointment 0.005% in patients with psoriasis of the face and intertriginous areas. 
    Poster abstract exhibit, AmericanAcademy of Dermatology 57th Annual Meeting, New Orleans, LA. March, 1999

  4. Duration of remission of psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: Comparison of maintenance treatments. 
    Poster abstract exhibit, AmericanAcademy of Dermatology, Academy ’99, New York, NY. 7.28.1999-8.1.1999.

  5. A histological examination of aluminum oxide microdermabrasion on facial skin. 
    Poster abstract exhibit, American Academy of Dermatology 58th Annual Meeting, San Francisco, CA. March, 2000.

  6. Orthopoxvirus from Sierra Leone
    Poster abstract exhibit, American Society of Dermatopathology 37th Annual Meeting, Baltimore, Maryland. October 19-22, 2000.

  7. The evaluation of aluminum oxide crystal microdermabrasion for photodamage. 
    Poster abstract exhibit, Mount Sinai Winter Symposium, Advances in Medical and Surgical Dermatology December 2000 New York, NY. Poster abstract exhibit, AmericanAcademy of Dermatology 59th Annual Meeting, WashingtonDC. March, 2001.

  8. Rhytid improvement after treatment with a new non-ablative pulse dye laser. 
    Poster abstract exhibit, AmericanAcademy of Dermatology 60th Annual Meeting, New Orleans, LA.February 21-26, 2002. Poster abstract exhibit, American Society of Laser Surgery, Atlanta, April, 2002.

  9. Clinical evaluation of enhanced nonablative skin rejuvenation using the 532nm laser and combination 532nm & 1064nm laser. 
    Poster abstract exhibit, American Society for Laser Medicine and Surgery, Laser 2003. Anaheim, California, April 9-13, 2002. Poster abstract exhibit, American Society for Dermatologic Surgery, combined Annual Meeting, New Orleans,LA.October 9-12, 2003.

  10. Long-term effects of Thermage treatment over dermal fillers in an animal model.
    Abstract presentation, American Society for Laser Medicine and Surgery, Laser 2005. Lake Buena Vista, Florida, March 30-April 3rd, 2005.

  11. Inpatient dermatology referrals from an Australian tertiary hospital.                                                                                               Clinical Research, Medical Dermatology Society, San Francisco, May 15-16, 2015. 

  12. Multiple pyogenic granulomas arising spontaneously within large capillary vascular malformations during pregnancy.             Poster abstract exhibit, Australasian College of Dermatologists, Annual Meeting, Perth, May 14-17, 2016.  

Public Presentations

Fraxel Resurfacing Workshop, Treating Physician - Australian College of Cosmetic Surgery, Adelaide, Australia, May 2006

Fraxel Workshop, Treating Physician - Eighth Annual  Mount Sinai Winter Symposium, Advances in Medical and Surgical Dermatology, New York, N.Y., December 2005

 

Memberships:

Diplomate of the American Board of Dermatology

Diplomate of the American Board of Dermatology

Fellow of the American Academy of Dermatology

Fellow of the American Academy of Dermatology

American Society for Dermatologic Surgery

American Society for Dermatologic Surgery

Teaching Affiliations:

Mount Sinai School of Medicine, New York N.Y. Residency in Dermatology

Mount Sinai School of Medicine, New York N.Y. Residency in Dermatology

St George Hospital, Sydney. VMO

St George Hospital, Sydney. VMO

Allergan, Trainer

Allergan, Trainer